MML Investors Services LLC cut its holdings in AMETEK, Inc. (NYSE:AME – Free Report) by 22.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 19,722 shares of the technology company’s stock after selling 5,564 shares during the period. MML Investors Services LLC’s holdings in AMETEK were worth $3,387,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in AME. Swedbank AB lifted its holdings in AMETEK by 223.8% in the second quarter. Swedbank AB now owns 67,858 shares of the technology company’s stock valued at $11,313,000 after acquiring an additional 46,903 shares during the last quarter. Blue Trust Inc. lifted its holdings in AMETEK by 95.8% in the second quarter. Blue Trust Inc. now owns 1,388 shares of the technology company’s stock valued at $254,000 after acquiring an additional 679 shares during the last quarter. Raymond James & Associates lifted its holdings in AMETEK by 11.5% in the second quarter. Raymond James & Associates now owns 172,180 shares of the technology company’s stock valued at $28,704,000 after acquiring an additional 17,762 shares during the last quarter. Vaughan Nelson Investment Management L.P. lifted its stake in AMETEK by 38.0% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 118,396 shares of the technology company’s stock worth $19,738,000 after purchasing an additional 32,602 shares in the last quarter. Finally, Apollon Wealth Management LLC lifted its stake in AMETEK by 59.9% during the second quarter. Apollon Wealth Management LLC now owns 11,880 shares of the technology company’s stock worth $1,981,000 after purchasing an additional 4,451 shares in the last quarter. 87.43% of the stock is currently owned by institutional investors and hedge funds.
AMETEK Stock Performance
NYSE:AME opened at $187.38 on Friday. The firm has a market capitalization of $43.34 billion, a PE ratio of 32.64, a price-to-earnings-growth ratio of 3.08 and a beta of 1.15. The business’s fifty day moving average price is $183.21 and its 200 day moving average price is $173.08. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.39 and a quick ratio of 0.84. AMETEK, Inc. has a 12 month low of $149.03 and a 12 month high of $198.33.
AMETEK Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a dividend of $0.28 per share. The ex-dividend date is Friday, December 6th. This represents a $1.12 annualized dividend and a dividend yield of 0.60%. AMETEK’s dividend payout ratio (DPR) is 19.51%.
Analyst Ratings Changes
A number of research firms have commented on AME. Mizuho upped their price target on AMETEK from $190.00 to $200.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. StockNews.com upgraded AMETEK from a “hold” rating to a “buy” rating in a research note on Wednesday, December 4th. Truist Financial upped their price target on AMETEK from $219.00 to $221.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. KeyCorp upped their price objective on AMETEK from $205.00 to $215.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Finally, Wolfe Research raised AMETEK to a “hold” rating in a research report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $199.29.
Check Out Our Latest Analysis on AMETEK
Insider Transactions at AMETEK
In other news, Director Steven W. Kohlhagen sold 1,460 shares of the stock in a transaction dated Wednesday, September 25th. The shares were sold at an average price of $171.59, for a total transaction of $250,521.40. Following the completion of the sale, the director now owns 23,349 shares in the company, valued at approximately $4,006,454.91. This represents a 5.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider David F. Hermance sold 6,243 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $190.99, for a total transaction of $1,192,350.57. Following the sale, the insider now owns 36,731 shares of the company’s stock, valued at $7,015,253.69. This trade represents a 14.53 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,660 shares of company stock worth $5,958,141. Company insiders own 0.61% of the company’s stock.
AMETEK Company Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Articles
- Five stocks we like better than AMETEK
- Investing in the High PE Growth Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- The Basics of Support and Resistance
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AME – Free Report).
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.